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Pathophysiologic basis for normouricosuric uric acid nephroli- uric acid levels with normal or high urinary uric acid ex-
thiasis. cretion [1–6]. A low urinary pH contributes to the forma-
Background: Low urinary pH is the commonest and by far tion of uric acid-containing kidney stones and appearsthe most important factor in uric acid nephrolithiasis but the
to be the most invariant feature of the syndrome [1, 2, 7].reason(s) for this defect is (are) unknown. Patients with uric acid
A low urinary pH5.5 results in a significant increase innephrolithaisis have normal acid-base parameters according
conventional clinical tests. the concentration of the sparingly soluble nondissociated
Methods: We studied steady-state plasma and urinary pa- uric acid that precipitates directly to form uric acid stones
rameters of acid-base balance in subjects with normouricosuric [8, 9]. Calcium oxalate stones can also develop from uricpure uric acid stones. We also tested the ability of these subjects
acid-induced crystallization of calcium salts [9–11].to excrete ammonium in response to an acute acid load. We
compared these parameters in patients with pure uric acid stones Low baseline urinary pH levels in uric acid stones form-
to patients with mixed uric acid/calcium oxalate stones, pure ers have been consistently described in uric acid stone
calcium stones, and normal volunteers. formers [12–19], although contradicting results have also
Results: Pure uric acid stone formers have a much higher
been reported [17, 20, 21]. The best explanation for theincidence of either diabetes or glucose intolerance. After equili-
low urinary pH is low ammonium ion (NH4 ) concentra-bration to a control diet, patients with uric acid stones have
lower urinary pH and they excrete less of their acid as ammo- tions in the urine [12, 14, 15] leaving the free H relatively
nium. This is compensated by higher titratable acidity and hypo- unbuffered. An implicit, but yet unproven, basis for uric
citraturia. Despite their low baseline urinary pH, uric acid stone acid nephrolithiasis in this syndrome is that there is anformers further acidify their urine after an acid load because
intrinsic defect in urinary NH4 excretion. Some studiesof a severely impaired ammonia excretory response. Their char-
showed that the low urinary NH4 in uric acid stone form-acteristics are significantly different from normal volunteers
and pure calcium stone formers. Patients with mixed uric acid/ ers is only detectable under special circumstances such
calcium stones exhibit intermediate characteristics. as high protein loading [21] or limitation of titratable acid
Conclusion: We propose that certain patients with normo-
precursors such as phosphate restriction [17]. Urinaryuricosuric uric acid nephrolithiasis have a renal acidification
NH4 excretion was shown to be blunted following chronicdisease. The primary defect lies in renal ammonium excretion,
which may be linked to the insulin-resistant state. Although net ammonium chloride (acid equivalent) load [12, 14, 21],
acid excretion is maintained at the expense of increased titrat- but ammoniagenic responses similar to control subjects
able acidity and to some degree hypocitraturia, the compromise have also been reported using chronic [13, 15, 20] as wellis acid urine pH and may result in uric acid nephrolithiasis.
as acute acid loading protocols [17]. The reasons for the
variability of these findings are not clear but may poten-
tially be related to differences in baseline acid excretion
Uric acid nephrolithiasis can result from different etio-
rate and availability of non-ammonia buffers. Cautionlogies [1, 2]. Patients can present with uric acid and/or
must be exercised to interpret urinary pH and NH4 .calcium oxalate kidney stones [3]. Biochemically, patients
Variable intake of acid/alkali load can influence the renalwith pure uric acid stones can have normal or high plasma
excretion of NH4 as well as urinary pH [22]. In the pres-
ence of increased buffering power by NH3 in response to
chronic acid loading, urinary pH is actually much higherKey words: Nephrolithiasis, uric acid, ammonium, urine pH, citrate,
insulin resistance. in situations of chronic acid loading compared to acute
acid loads [23, 24]. A study performed under strictlyReceived for publication October 19, 2001
controlled dietary conditions has not been performed.and in revised form March 14, 2002
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tients with uric acid stones with a given dietary acid load were maintained on same constant metabolic diet at the
General Clinical Research Center (GCRC) for 3 daysand whether this defect in NH4 excretion and acid uri-
nary pH can be amplified or unmasked after a single (study days 5 to 7). During the last two days of metabolic
diet (study days 6 and 7), 24-hour urine samples wereacute acid load. We studied 21 patients with “pure” uric
acid stones and compared the parameters to those of collected under mineral oil and refrigerated for measure-
ments of total volume, pH, creatinine, sodium, potassium,normal volunteers. We also compared the uric acid stone
formers to patients with calcium oxalate stones (who calcium, phosphorus, chloride, uric acid, oxalate, citrate,
sulfate, ammonium, titratable acidity, and bicarbonate/should have a completely different clinical phenotype)
as well as patients with mixed uric acid/calcium stones carbon dioxide). Fasting venous blood samples were ob-
tained before breakfast on days 7 and 8 for electrolytes,(who may exhibit some features similar to patients with
uric acid nephrolithiasis). creatinine, urea nitrogen, calcium, phosphorus, uric acid,
glucose, cholesterol, and triglycerides. On the evening
of day 7, subjects fasted except for 300 mL distilled water
METHODS
at bedtime.
Experimental subjects On the morning of day 8, an ammonium chloride
(NH4Cl) loading test was performed. Breakfast was with-We studied four groups of patients. The normal group
was composed of 18 normal volunteers (12 males and held. Urine was collected hourly from 7:00 a.m. to 12:00
noon under mineral oil. At 8:00 a.m., 50 mEq NH4Cl insix females; mean age, 39 years; range, 23 to 61 years).
The three groups of stone-forming patients were identi- gelatin capsules was administered orally with 250 mL
water. To ensure adequate urine output, 250 mL waterfied by records of stone analysis. The uric acid stone-
former group consisted of 21 patients with “pure” acid was drunk at 7:00, 8:00, 9:00, 10:00, and 11:00 a.m. Hourly
urine samples were analyzed for the following compo-stones (18 males and three females; mean age, 56 years;
range, 36 to 77 years). We excluded two patients with nents: total volume, pH, creatinine, ammonium, titrat-
able acidity and bicarbonate. Arterialized venous bloodpure uric acid stones because their daily urinary uric acid
excretion were consistently above 600 mg. Eight patients was obtained (venous blood drawn without stasis from an
antecubital vein after a 30-minute application of electrichad “mixed” uric acid/calcium oxalate nephrolithiasis
(five males and three females; mean age, 53 years; range, warm pack to the forearm) for chemistry and pH and
blood gases were obtained at 7:00, 10:00 and 12:00 a.m.39 to 62 years). Twenty-three patients with “pure” cal-
cium oxalate nephrolithiasis (19 males and four females;
Analytical procedures and calculationsmean age, 48 years; range, 17 to 69 years). None of the
patients had daily urinary uric acid exceeding 600 mg. Serum sodium, potassium, chloride, total carbon diox-
ide, calcium, phosphorus, glucose, triglyceride, choles-Patients and normal volunteers with chronic diarrheal
illness, renal disease, urinary tract infection, liver disease, terol, blood urea nitrogen, uric acid, and creatinine con-
centrations were obtained as a part of 24-hour chemistrycardiovascular disease, abnormal thyroid function tests,
or proteinuria were excluded. Subjects who were re- (GCRC Core Laboratory using Beckman CX9ALX, Ful-
lerton, CA, USA). Urinary calcium (performed in anceiving converting enzyme inhibitors, angiotensin recep-
tor blockers,  blockers, non-steroidal anti-inflammatory acidified aliquot to prevent precipitation) was deter-
mined by atomic absorption spectrophotometry. Sodiumagents, lipid-altering drugs, as well as participating in
strenuous physical exercise program, were also excluded and potassium were measured by flame photometry. Uri-
nary chloride was measured coulometrically by silverfrom the study. The patients with nephrolithiasis were
instructed to discontinue all medications for renal stones precipitation. Uric acid (done in an alkalinized aliquot
to prevent precipitation) was analyzed by the uricase(thiazide, allopurinol, alkali). No one received drugs that
could affect urate metabolism (such as high-dose acetyl- method and creatinine by the picric acid method. Urinary
phosphorus was measured by a colorimetric technique.salicylate). Institutional Review Board committee ap-
proved the study and informed consent was obtained Urinary pH was measured with a pH electrode. Urinary
citrate was determined enzymatically using reagentsfrom each of the participating subjects.
from Boehringer-Mannheim Biochemicals (Indianapo-
Study protocol lis, IN, USA). Urinary ammonium was determined by
the glutamate dehydrogenase method. Urinary sulfateThe study included an outpatient evaluation and a
stabilization phase during which subjects were main- was determined by ion chromatography. Urinary titrat-
able acidity was measured directly using automatedtained on a constant frozen metabolic diet with a daily
composition of 400 mg calcium, 800 mg phosphorus, 100 burette end-point titration system (Radiometer, Copen-
hagen, Denmark) and was also calculated from concen-mEq sodium, 40 mEq potassium, sufficient fluid (distilled
water) to ensure about 2 L of urine, with a fixed acid ash trations of different ionic species and complexes ob-
tained from urinary stone risk factors using the computercontent for 4 days. After 4 days of stabilization, subjects
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Table 1. Plasma chemistries
Stone formers
Normal Uric acid Mixed Calcium oxylate
Number 18 21 8 23
Gender male/female 12/6 18/3 5/3 19/4
Age years 3911c 5611 539 4813
BMI kg/m2 296a 357 338 347
Diabetic % 0 33.3 37.5 0
Glucose Intolerant % 0 23.8 0 8.7
Triglyceride mg/dL 10053c 299223 187105 229160
Median 76 215 164 193
Cholesterol mg/dL 18935 21046 21049 21240
Blood urea nitrogen mg/dL 113b 167 124 133
Creatinine mg/dL 1.00.2 1.10.4 1.00.2 1.00.2
Sodium mEq/L 1372 1363 1393 1383
Potassium mEq/L 4.00.3 4.10.4 3.90.3 4.20.7
Chloride mEq/L 1053 1043 1054 1043
HCO3 mEq/L 272 262 282 272
PCO2 mm Hg 464 455 473 464
pH 7.380.02 7.370.03 7.370.05 7.390.03
Calcium mg/dL 9.20.4 9.30.5 9.20.3 9.30.7
Phosphorus mg/dL 3.40.5 3.30.4 3.60.8 3.10.5
Uric acid mg/dL 5.62c 8.11.8 7.72.1 6.61.5b
Data presented as mean  SD. Significant differences from uric acid stone formers depicted by a for P  0.02; b for P  0.01; and c for P  0.001.
program of Finlayson [25]. The milliequivalents of OH stones, and patients with pure calcium oxalate stones.
required bring the original pH to pH 7.4 yielded titrat- Characteristics of the study patients are shown in Table 1.
able acidity (TA). Net acid excretion was calculated as Uric acid stone formers were older than normal controls.
(NH4  TA)  (HCO3  ionized citrate); all expressed Ethnic origin (overall distribution was 80% Caucasians,
in milliequivalents. Urinary HCO3 was calculated from 5.7% African Americans, 8.5% Hispanic, and 5.7% Asian)
urinary pH and PCO2 and milliequivalents of ionized ci- and gender distribution was not significantly different
trate were calculated from urinary pH and a pKa of among the four groups. The mean body mass index (in
citrate2/citrate3 of 5.6. Arterialized venous blood and kg/m2) was higher in uric acid stone formers than in nor-
urinary pH and blood and urinary carbon dioxide were mal volunteers. The mean body mass index was not dif-
determined aerobically at 37C [Radiometer BMS-3 pH ferent among the stone-forming groups. Age and body
electrode (Copenhagen, Denmark) and Servinghaus mass index were not significant covariates. Analysis of
PCO2 electrode]. The arterialized venous plasma bicarbon- covariance results adjusting for age and body mass index
ate concentration was calculated from blood pH and were similar to the unadjusted analysis. Since age and
PCO2 (Henderson-Hasselbach equation). body mass index did not affect the results, only unad-
justed analyses are shown. Since the 24-hour urinary cre-Statistical analysis
atinine excretion was similar in all groups reflecting simi-
Two sample t tests were used to compare pure uric lar lean body mass, the difference in body mass index
acid stone formers to normal volunteers, mixed uric acid/ was likely due to differences in body fat. Uric acid stone
calcium oxalate stone formers, and pure calcium oxalate formers had a much higher incidence of diabetes (on
stone formers. For skewed data, log transformations treatment with insulin or oral hypoglycemic agents) or
were employed prior to analysis. The level of significance glucose intolerance (fasting blood glucose 110 mg/dL)
was alpha  0.02 level, using the Bonferroni inequality
compared to all other groups.to adjust for multiple testing. Statistical analysis was per-
formed with SAS 8.0 (SAS Institute, Cary, NC, USA). Plasma chemistry
Results are expressed as mean  standard deviation.
Serum triglyceride concentration was significantly higherAnalysis of covariance models were used to adjust for
in uric acid stone formers than normal controls (Table 1).the potential confounding effects of covariates age and
No significant difference was found in serum total choles-body mass index on group comparisons.
terol concentration among all four groups. Serum uric
acid concentration exceeded the upper limit (7.5 mg/dL)
RESULTS and was significantly higher in uric acid stone group
Patient characteristics than normal volunteers and pure calcium oxalate stone
formers but similar to the patients with mixed stones.Comparisons were made between the uric acid stone
formers and normal volunteers, patients with mixed This degree of hyperuricemia is similar to our previous
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Table 2. Urinary data
Stone formers
Normal Uric acid Mixed Calcium oxylate
Number 11 187 8 19
Total volume mL/day 2341879 2273846 2714546 2657450
Creatinine mg/day 1750483 1696510 1611483 1848492
Sodium mEq/day 11092 8031 7426 9538
Potassium mEq/day 4011 359 3416 3411
Chloride mEq/day 10076 7530 6925 8732
Calcium mg/day 15183 9849 17173b 19891c
Phosphorus mg/day 732298 757216 743180 728145
Oxalate mg/day 237 308 286 358
Uric acid mg/day 498104 379150 553183a 607134c
FEUA 4.11.2 3.31.9 5.22.3 5.01.7b
Sulfate mEq/day 3717 408 3913 377
pH 5.960.47c 5.400.23 5.680.47 6.020.35c
NH4 mEq N/day 329 3311 3613 3913
TA mEq/day 2310b 337 268 237c
Citrate mg/day 705418a 317219 415208 466331
Median 745 278 337 358
Citrate mEq/day 8.85.3a 4.43.0 5.53.0 5.63.9
Median 8.8 3.9 4.3 4.2
NAE mEq/day 4614a 6114 5617 5519
NH4 /NAE 0.740.28d 0.530.10 0.650.10b 0.710.09c
TA/NAE 0.500.15 0.540.10 0.480.15 0.430.09c
Citrate (mEq)/NAE 0.170.10a 0.070.05 0.120.10 0.110.08
Sulfate (mEq)/NAE 0.910.48 0.670.15 0.750.34 0.720.27
Creatinine clearance mL/min 13534 11341 10922 12934
Abbreviations are: FEUA, fractional excretion of uric acid; TA, titratable acidity; NAE, net acid excretion. Data presented as mean  SD. Significant differences
from uric acid stone formers depicted by a for P  0.02, b for P  0.01 and c for P  0.001; d  0.01 after log transformation.
series [6]. No significant differences were found between oxalate stone formers (Table 2). The 24-hour mean uri-
nary pH was not different between the pure uric acidpure uric acid stone formers and the other groups in
blood urea nitrogen, serum creatinine, sodium, potas- versus the mixed stone formers. Urinary ammonium did
not differ significantly (P  0.13) between the groupssium, chloride, bicarbonate, arterialize venous pH, PCO2,
but was numerically lower in the pure uric acid groupcalcium, and phosphorus (Table 1).
compared to the pure calcium oxalate group. We re-
Urinary chemistry ported a similar finding of a trend toward lower total
urinary ammonium in uric acid stone-formers in our pre-The mean 24-hour urinary uric acid did not differ sig-
nificantly between the pure uric acid stone formers and vious report [6]. The mean urinary titratable acidity was
significantly higher in the pure uric acid stone group thanthe normal controls (Table 2), even though the value
was numerically lower in uric acid group. However, com- both the normal volunteers and pure calcium oxalate
stone formers. Urinary citrate excretion was not differentpared to the pure uric acid group, urinary uric acid was
significantly higher in mixed uric acid/calcium oxalate among the three groups of stone formers but was lower
than the normal volunteers. Net acid excretion in thestone and pure calcium oxalate stone formers (Table 2).
Fractional urate/uric acid excretion was significantly pure uric acid stone formers was slightly but significantly
higher than the normal volunteers but similar to thehigher in pure calcium oxalate stone formers compared
to pure uric acid stone formers. No significant difference other two groups of stone-formers.
Several patterns are appreciated in Figure 1. The pri-was found between the uric acid stone formers and other
groups in urinary volume, sodium, potassium, chloride, mary data from each individual patient are shown in
Figure 2. Note that despite prescription of fixed diet, therecalcium, phosphorus, oxalate, creatinine and endoge-
nous creatinine clearance. The latter two findings indi- were considerable variations in net acid excretion. We
plotted the individual urinary pH, NH4 , and titratablecate that all four groups of subjects had similar lean
muscle mass, similar levels of renal function, and con- acid against net acid excretion to peruse the difference
between the groups. Even in the background of overlap,sumed equivalent diets.
The 24-hour urine data for each subject are shown in one can appreciate the lower urinary pH and lower
NH4 and higher titratable acid content for a given netFigure 1 and the summary is in Table 2. The 24-hour
mean urinary pH was significantly lower in the pure uric acid excretion in uric acid stone formers compared to
normal controls  s or pure calcium oxalate stone for-acid stone formers than the controls and pure calcium
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Fig. 1. Primary urinary data from individual patients. Urine collections
were taken every 24 hours from each of the four groups of patients.
Urine pH (A), ammonium (NH4 ) (B), or titratable acid (C ) are plotted
against net acid excretion (NAE). Symbols are: (), uric acid stone
formers; (), normal volunteers; (), mixed calcium oxylate/uric acid
stone formers; () calcium oxylate stone formers.
mers (Fig. 1). When urinary NH4 was plotted against
urinary pH (Fig. 2), one can appreciate that patients with
either pure uric acid stones or mixed uric acid/calcium
oxalate stones segregated from the other two groups.
Although we did not find a significant difference in 24-
hour urinary NH4 among the groups, the fraction of net
acid excreted as ammonium (NH4 /net acid excretion
ratio) was significantly lower in patients with pure uric
acid stones than in both the mixed and pure calcium
oxalate stone formers (Table 2). In addition, all patients
with nephrolithiasis have lower urinary citrate excretion
compared to normal controls (Table 2). For all the find-
ings described above, patients with mixed uric acid/cal-
cium oxalate stones were either similar to patients with
Fig. 2. Primary urinary data from individual patients. Urine collections
pure uric acid stones or somewhat intermediate between were taken every 24 hours from each of the four groups of patients.
Urinary pH is plotted against net acid excretion (NAE).the pure uric acid stone formers and normal controls.
Response to an acute acid (NH4Cl) load single dose of oral NH4Cl (50 mEq) and examined the
To further examine if there is an impediment to excrete urinary acidification parameters before and every hour
NH4 , we challenged the 21 patients with uric acid stones after the load for 4 hours. The peak urinary NH4 response
was observed at 2 hours in 80% of the patients with theand the 49 patients from the other three groups with a
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Fig. 3. Urinary response to acute acid load
for each individual patient. After equilibration
on a standard diet, patients were given an oral
load of 50 mmol/L NH4Cl and hourly urine
samples were collected for pH, NH4 , and cre-
atinine determinations. NH4 were normalized
to urinary creatinine (NH4 /Cr). Difference
between the baseline and the peak ammonium
excretory response (	NH4 /Cr) is on the y axis.
The corresponding starting and final urinary
pH is on the x axis and each pair of urinary
pH’s are connected by a line. The open end
of the lines denote starting urinary pH and
the symbol end of the lines denote the final
urinary pH. Symbols are: in (A) (), uric acid
stone formers; (), normal volunteers. In (B),
() uric acid stone formers; () mixed cal-
cium oxylate/uric acid stone formers. In (C ),
() uric acid stone formers; () calcium oxy-
late stone formers.
Fig. 4. Urinary response to acute acid load.
After equilibration on a standard diet, patients
were given an oral load of 50 mmol/L NH4Cl.
Urinary pH () and values for NH4 () and
NH3 () (normalized for creatinine) pre- and
post-acid load are plotted for the four groups
of patients. Symbols and bars denote mean 
SE. Statistically significant differences (P 
0.05, ANOVA) are indicated as follows: *, com-
pared to pre-load NH4 /Cr in uric acid stone-
formers; **, compared to post-load NH4 /Cr
in uric acid stone formers; #, compared to pre-
load NH4 /Cr in uric acid stone formers; ##,
compared to post-load NH4 /Cr in uric acid
stone formers; †, compared to pre-load NH4 /
Cr in uric acid stone formers; ††, compared to
post-load NH4 /Cr in uric acid stone formers.
remaining 20% peaking at 3 hours. The patients clearly uric acid and mixed uric acid/calcium stone formers had
the lowest end urinary pH after the acid load (5.26 segregated into two easily discernible groups (Fig. 3).
Patients with pure uric acid stones and mixed uric acid 0.35) compared to normal controls, mixed stone formers,
and pure calcium stone formers (5.64  0.54, 5.37 stones were different from pure calcium oxalate stone
formers and normal volunteers. Urinary pH decreased 0.47, 5.64  0.47, respectively) (Figs. 3 and 4). The rise
in NH4 excretion rate (normalized to creatinine) abovein all patients studied. The starting urinary pHs were
higher in normal volunteers (mean  SD, 6.16  0.57) baseline was five- to sevenfold higher in normal controls
(15.8  9.7 
Eq/mg) and pure calcium oxalate stone-and patients with pure calcium oxalate stones (6.12 
0.43) compared to patients with pure uric acid (5.47  forming patients (12.7  6.2 
Eq/mg) compared to
pure uric acid stone formers (2.2  4.4 
Eq/mg) and0.42) or mixed stones (5.76  0.61). There were also
greater falls in urinary pH in normal volunteers (0.52 twice that of mixed uric acid/calcium oxalate stone for-
mers (7.0  11.3 
Eq/mg). The poor ammonium re-0.48) and patients with pure calcium oxalate stones
(0.48  0.34) compared to patients with pure uric acid sponse was due to the extremely low NH3 available in
uric acid and mixed uric acid/calcium stone formers com-(0.21  0.30) or mixed stones (0.39  0.23). (Fig. 4).
Despite the smaller decrease in urinary pH, the pure pared to normal controls or pure calcium stone formers
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(Fig. 4). The individual primary data points are shown may also account for the discrepancy [17]. In the present
study, we attempted to control all variables by equilibrat-in Figure 3 where the rise in NH4 excretion in response
to each acid load in a given individual was plotted against ing the patients on the same metabolic diet but we still
observed some degree of scatter in daily net acid secre-the beginning and end urinary pH. The dramatic differ-
ence in NH4 excretion is evident in this plot where there tion (see primary data in Figs.1 and 2). The equivalence
of urinary Na, K, sulfate, and phosphate among the fourwas virtually no overlap between the pure uric acid stone
formers with the pure calcium oxalate stone formers (Fig. groups suggests that the subjects were probably compli-
ant with the diet. The slightly lower net acid excretion3C) and normal volunteers (Fig. 3A) in terms of ammo-
nium excretory response to the acid load. The response in normal volunteers may be due to lower endogenous
acid production, less gastrointestinal alkali loss, or both.was very similar between the uric acid and mixed stone-
formers (Fig. 3B) except for one outlying point. Patients with either pure or mixed uric acid stones have
lower urinary pH and higher titratable acid. Although
baseline NH4 /day were not statistically different, theDISCUSSION
fraction of H excreted as NH4 (NH

4 /net excretion rate
This is the largest study to date that examined whether ratio), this number is clearly lower in patients with pure
defective renal ammonia excretion underlies uric acid uric acid stones (53%) and mixed uric acid/calcium oxa-
urolithiasis under conditions of controlled dietary acid late stones (65%) compared to normal controls (74%)
and phosphorus intake. Our data demonstrate that such and patients with pure calcium oxalate stones (71%).
a defect in ammonium excretion would account for the Since the relationship between urinary pH and NH4
undue urinary acidity, the fundamental deficit leading is inconsistent in a chronic steady state [26], we chal-
to uric acid nephrolithiasis [18, 19]. There are three major lenged our patients with a standard acid load in the back-
findings in this study. First, patients with either pure uric ground of equilibration to a controlled diet. All patients
acid or mixed uric acid/calcium oxalate stones excrete mounted a response with increased urinary ammonium
less of their net acid as ammonium due to a defect in excretion as expected. Patients with pure uric acid stones
ammonium excretion at the steady state; the end result clearly have a lower ammonium excretory response com-
being acidic urinary pH. Second, despite a mild defect pared to normal controls or patients with calcium oxalate
in ammonium excretion, patients with either pure uric stones, whereas the response is by-and-large indistinguish-
acid or mixed uric acid/calcium oxalate stones have nor- able between the pure uric acid and mixed uric acid/
mal systemic acid-base parameters and normal net acid calcium stone formers. Despite their low baseline urinary
excretion. Since a lesser portion of their acid is excreted pH, uric acid stone formers further acidified their urine
as urinary ammonium, net acid excretion is compensated in response to an acute acid load. Patients with mixed
by increased titratable acidity and hypocitraturia. Fi- uric acid/calcium oxalate stones behaved similarly to
nally, there is a high incidence of either glucose intoler- those with pure uric acid stones in terms of ammonium
ance or frank type II diabetes in patients with pure uric excretory response. The calcium oxalate precipitation
acid stones compared to patients with calcium oxalate could well be secondary to uric acid-induced calcium ag-
stones. The incidences of type II diabetes or glucose gregation [9–11]. We postulate that uric acid nephrolithi-
intolerance in patients with mixed uric acid/calcium oxa- asis is primarily an “acidification disease” with uric acid
late stones are intermediate between the pure uric acid precipitation occurring as an “innocent bystander.”
and pure calcium oxalate stone formers. It is noteworthy that all the patients have normal
Low urinary pH is the single most invariable finding steady-state systemic acid-base parameters and all seem
in pure uric acid nephrolithiasis. There is little doubt to excrete their daily acid load adequately (Tables 1
that the low urinary pH is pathogenic for uric acid precip- and 2). While the defect brought out by the acute acid
itation in the urine. Low ammonium excretion as a cause load (which takes the system to capacity) seems severe
of low urinary pH has been described in some studies, (13% of normal, Table 3), the decrease in urinary ammo-
but not in others [6, 12–17, 20, 21]. Part of the discrepancy nium is relatively minor at the steady state and is com-
may arise from the small difference in ammonium excre- pensated by a higher titratable acid content, as well as
tion required to lower urinary pH at the typical urinary a lower urinary citrate excretion. The higher titratable
pH values encountered in these patients so biochemically acid is likely accountable entirely by the lower urinary
significant differences may not be statistically significant. pH because there is no increase in phosphate, creatinine,
Another is the variation in net acid production and excre- or uric acid excretion in the patients with pure uric acid
tion in any given individual from day to day. Plante, stones. Although hypocitraturia is well known in patients
Durivage, and Lemieux noted that a high protein diet with pure calcium oxalate and mixed uric acid/calcium
(presumed high acid load) was required for the abnormal stones, low urinary citrate has not been previously re-
urinary parameter to manifest [21]. The variation in lev- ported in patients with pure uric acid stones, including
our previous analysis using random outpatient urine col-els of alternative H acceptors such as urinary phosphate
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lection [6]. The hypocitraturia may be secondary to prox- cation. This mild defect does not lead to any acid-base
abnormalities but uric acid precipitates as an innocentimal tubule cell acidification, which increases apical mem-
brane citrate uptake [27, 28], as well as cellular citrate bystander in the acidic urine.
metabolism [29, 30]. Although the mean urinary citrate
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